<p>Teladoc Health（纽约证券交易所代码：TDOC - 获取免费报告）在周五发布的研究报告中，花旗将其目标价格从 11.00 美元下调至 8.75 美元，Benzinga 报道。该公司目前对这家健康服务提供商的股票给予 “中性” 评级。花旗的目标价格意味着与该公司之前收盘价相比，潜在上涨幅度为 21.61%。</p>
<p>获取 <strong>Teladoc Health</strong> 警报：</p>
<ul>
<li>2 只可能受益于特朗普新任 FDA 官员的远程医疗股票</li>
</ul>
<p>TDOC 曾是几份其他研究报告的主题。Oppenheimer 将 Teladoc Health 的目标价格从 14.00 美元下调至 12.00 美元，并在 1 月 24 日的研究报告中给予该公司 “跑赢大盘” 的评级。高盛将 Teladoc Health 的目标价格从 16.00 美元下调至 13.00 美元，并在 3 月 3 日的研究报告中给予该股票 “买入” 评级。加拿大皇家银行将 Teladoc Health 的目标价格从 11.00 美元上调至 12.00 美元，并在 1 月 24 日的研究报告中给予该公司 “跑赢大盘” 的评级。Jefferies Financial Group 在周一的研究报告中将 Teladoc Health 的目标价格从 10.00 美元下调至 8.00 美元，并对该股票给予 “持有” 评级。最后，Needham &amp; Company LLC 在 2 月 27 日的研究报告中重申了对 Teladoc Health 股票的 “持有” 评级。十二位分析师对该股票给予了持有评级，七位分析师给予了买入评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “持有”，平均目标价格为 10.71 美元。</p>
<p><strong>查看我们最新的 TDOC 股票报告</strong></p>
<h2>Teladoc Health 股票下跌 0.9%</h2>
<ul>
<li>2 只曾经的疫情明星股票瞄准 2025 年的大反弹</li>
</ul>
<p>在周五的午盘交易中，Teladoc Health 股票下跌 0.07 美元，达到 7.20 美元。该公司的股票交易量为 466,899 股，而其平均交易量为 6,220,314 股。该公司的 50 日简单移动平均线为 8.63 美元，200 日简单移动平均线为 9.58 美元。该公司的市值为 12.6 亿美元，市盈率为-1.25，贝塔值为 1.73。Teladoc Health 的 52 周低点为 6.35 美元，52 周高点为 15.21 美元。该公司的速动比率为 1.69，流动比率为 1.73，债务与股本比率为 0.66。</p>
<p>Teladoc Health（纽约证券交易所代码：TDOC - 获取免费报告）最后一次公布季度财报是在 2 月 26 日。该健康服务提供商报告的每股收益（EPS）为-0.28 美元，低于分析师一致预期的-0.21 美元，差距为 0.07 美元。Teladoc Health 的净利润率为-37.91%，股本回报率为-10.06%。该公司在本季度的收入为 6.4049 亿美元，而分析师预期为 6.3944 亿美元。研究分析师预计 Teladoc Health 在当前财政年度的每股收益将为-1.16 美元。</p>
<h2>Teladoc Health 的内部活动</h2>
<ul>
<li>Doximity：‘医生的 Facebook’ 在财报超预期后大幅上涨</li>
</ul>
<p>在相关消息中，内部人士 Adam C. Vandervoort 在 3 月 20 日的交易中出售了 11,011 股该股票。股票以平均价格 8.42 美元出售，总价值为 92,712.62 美元。出售后，该内部人士现在直接持有 64,308 股公司股票，价值约为 541,473.36 美元。这代表其持股减少了 14.62%。该出售在与证券交易委员会的法律文件中披露，文件可在此链接查看。公司内部人士目前持有该股票的 0.58%。</p>
<h2>Teladoc Health 的机构交易</h2>
<p>几家大型投资者最近调整了对 TDOC 的持股。Golden State Wealth Management LLC 在第一季度将其在 Teladoc Health 的持股增加了 102.6%。Golden State Wealth Management LLC 现在拥有 3,337 股该健康服务提供商的股票，价值 27,000 美元，此前在上个季度又购买了 1,690 股。Versant Capital Management Inc 在第四季度将其在 Teladoc Health 的持股增加了 313.8%。Versant Capital Management Inc 现在拥有 3,219 股该健康服务提供商的股票，价值 29,000 美元，此前在上个季度又收购了 2,441 股。Whipplewood Advisors LLC 在第四季度购买了 Teladoc Health 的新股份，价值约为 29,000 美元。Lindbrook Capital LLC 在第四季度将其在 Teladoc Health 的持股增加了 78.9%。Lindbrook Capital LLC 现在拥有 3,654 股该健康服务提供商的股票，价值 33,000 美元，此前在上个季度又购买了 1,612 股。最后，Sterling Capital Management LLC 在第四季度将其在 Teladoc Health 的持股增加了 776.7%。Sterling Capital Management LLC 现在拥有 4,629 股该健康服务提供商的股票，价值 42,000 美元，此前在上个季度又购买了 4,101 股。目前 76.82% 的股票由机构投资者和对冲基金持有。</p>
<h2>关于 Teladoc Health</h2>
<p>（获取免费报告）</p>
<p>Teladoc Health, Inc 在全球提供虚拟医疗服务。该公司通过 Teladoc Health 综合护理和 BetterHelp 两个部门运营。综合护理部门提供虚拟医疗服务，包括普通医疗、专家医疗、专科医疗、慢性病管理和心理健康，以及为医院和健康系统提供的技术和企业远程医疗解决方案。</p>
<h2>另请参阅</h2>
<ul>
<li>五只我们更看好的股票，胜过 Teladoc Health</li>
<li>股息筛选器：如何在购买前评估股息股票</li>
<li>空头最近放弃了这 3 只股票</li>
<li>除了喝咖啡，还有 3 种投资咖啡的方法</li>
<li>3 只表现优于市场的无聊股票</li>
<li>内部交易 - 你需要知道的事项</li>
<li>如果你想购买 AbbVie 却没有，现在仍然有机会购买</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRET0M?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRET0M"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在 Teladoc Health 吗？</h2>
<p>在考虑 Teladoc Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Teladoc Health 并不在名单上。</p>
<p>虽然 Teladoc Health 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

TDOC

<p>花旗集团已将 Teladoc Health（纽约证券交易所代码：TDOC）的目标股价从 11.00 美元下调至 8.75 美元，维持 “中性” 评级。这一调整表明与前一交易日收盘价相比，潜在上涨幅度为 21.61%。其他分析师也调整了他们的目标价，Oppenheimer 将其设定为 12.00 美元，高盛则为 13.00 美元。目前，Teladoc 的股票交易价格为 7.20 美元，下跌 0.9%，平均评级为 “持有”，来自十二位分析师的目标价为 10.71 美元。该公司在上个季度报告的每股亏损为 0.28 美元，未能达到预期</p>

<p>Teladoc Health (NYSE:TDOC - Get Free Report) had its price objective cut by Citigroup from $11.00 to $8.75 in a research report issued on Friday,Benzinga reports. The firm presently has a &#34;neutral&#34; rating on the health services provider's stock. Citigroup's price objective would indicate a potential upside of 21.61% from the company's previous close.</p>
<div class="lb-trans"><p>Teladoc Health（纽约证券交易所代码：TDOC - 获取免费报告）在周五发布的研究报告中，花旗将其目标价格从 11.00 美元下调至 8.75 美元，Benzinga 报道。该公司目前对这家健康服务提供商的股票给予 “中性” 评级。花旗的目标价格意味着与该公司之前收盘价相比，潜在上涨幅度为 21.61%。</p>
</div><p>Get <strong>Teladoc Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Teladoc Health</strong> 警报：</p>
</div><ul>
<li>2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只可能受益于特朗普新任 FDA 官员的远程医疗股票</li>
</ul>
</div><p>TDOC has been the subject of several other research reports. Oppenheimer decreased their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an &#34;outperform&#34; rating for the company in a research note on Friday, January 24th. The Goldman Sachs Group dropped their price target on Teladoc Health from $16.00 to $13.00 and set a &#34;buy&#34; rating on the stock in a research note on Monday, March 3rd. Royal Bank of Canada boosted their price objective on Teladoc Health from $11.00 to $12.00 and gave the company an &#34;outperform&#34; rating in a research note on Friday, January 24th. Jefferies Financial Group lowered their target price on shares of Teladoc Health from $10.00 to $8.00 and set a &#34;hold&#34; rating on the stock in a research report on Monday. Finally, Needham &amp; Company LLC reiterated a &#34;hold&#34; rating on shares of Teladoc Health in a research report on Thursday, February 27th. Twelve analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of &#34;Hold&#34; and an average price target of $10.71.</p>
<div class="lb-trans"><p>TDOC 曾是几份其他研究报告的主题。Oppenheimer 将 Teladoc Health 的目标价格从 14.00 美元下调至 12.00 美元，并在 1 月 24 日的研究报告中给予该公司 “跑赢大盘” 的评级。高盛将 Teladoc Health 的目标价格从 16.00 美元下调至 13.00 美元，并在 3 月 3 日的研究报告中给予该股票 “买入” 评级。加拿大皇家银行将 Teladoc Health 的目标价格从 11.00 美元上调至 12.00 美元，并在 1 月 24 日的研究报告中给予该公司 “跑赢大盘” 的评级。Jefferies Financial Group 在周一的研究报告中将 Teladoc Health 的目标价格从 10.00 美元下调至 8.00 美元，并对该股票给予 “持有” 评级。最后，Needham &amp; Company LLC 在 2 月 27 日的研究报告中重申了对 Teladoc Health 股票的 “持有” 评级。十二位分析师对该股票给予了持有评级，七位分析师给予了买入评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “持有”，平均目标价格为 10.71 美元。</p>
</div><p><strong>View Our Latest Stock Report on TDOC</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 TDOC 股票报告</strong></p>
</div><h2>Teladoc Health Stock Down 0.9 %</h2>
<div class="lb-trans"><h2>Teladoc Health 股票下跌 0.9%</h2>
</div><ul>
<li>2 Former Pandemic Darlings Eyeing a Big 2025 Turnaround</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只曾经的疫情明星股票瞄准 2025 年的大反弹</li>
</ul>
</div><p>Teladoc Health stock traded down $0.07 during midday trading on Friday, reaching $7.20. The company's stock had a trading volume of 466,899 shares, compared to its average volume of 6,220,314. The business has a 50-day simple moving average of $8.63 and a 200-day simple moving average of $9.58. The company has a market cap of $1.26 billion, a P/E ratio of -1.25 and a beta of 1.73. Teladoc Health has a fifty-two week low of $6.35 and a fifty-two week high of $15.21. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.</p>
<div class="lb-trans"><p>在周五的午盘交易中，Teladoc Health 股票下跌 0.07 美元，达到 7.20 美元。该公司的股票交易量为 466,899 股，而其平均交易量为 6,220,314 股。该公司的 50 日简单移动平均线为 8.63 美元，200 日简单移动平均线为 9.58 美元。该公司的市值为 12.6 亿美元，市盈率为-1.25，贝塔值为 1.73。Teladoc Health 的 52 周低点为 6.35 美元，52 周高点为 15.21 美元。该公司的速动比率为 1.69，流动比率为 1.73，债务与股本比率为 0.66。</p>
</div><p>Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. On average, research analysts expect that Teladoc Health will post -1.16 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Teladoc Health（纽约证券交易所代码：TDOC - 获取免费报告）最后一次公布季度财报是在 2 月 26 日。该健康服务提供商报告的每股收益（EPS）为-0.28 美元，低于分析师一致预期的-0.21 美元，差距为 0.07 美元。Teladoc Health 的净利润率为-37.91%，股本回报率为-10.06%。该公司在本季度的收入为 6.4049 亿美元，而分析师预期为 6.3944 亿美元。研究分析师预计 Teladoc Health 在当前财政年度的每股收益将为-1.16 美元。</p>
</div><h2>Insider Activity at Teladoc Health</h2>
<div class="lb-trans"><h2>Teladoc Health 的内部活动</h2>
</div><ul>
<li>Doximity: The 'Facebook for Doctors' Surges After Earnings Beat</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity：‘医生的 Facebook’ 在财报超预期后大幅上涨</li>
</ul>
</div><p>In related news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the sale, the insider now directly owns 64,308 shares of the company's stock, valued at approximately $541,473.36. This represents a 14.62 % decrease in their position. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available at this hyperlink. 0.58% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在相关消息中，内部人士 Adam C. Vandervoort 在 3 月 20 日的交易中出售了 11,011 股该股票。股票以平均价格 8.42 美元出售，总价值为 92,712.62 美元。出售后，该内部人士现在直接持有 64,308 股公司股票，价值约为 541,473.36 美元。这代表其持股减少了 14.62%。该出售在与证券交易委员会的法律文件中披露，文件可在此链接查看。公司内部人士目前持有该股票的 0.58%。</p>
</div><h2>Institutional Trading of Teladoc Health</h2>
<div class="lb-trans"><h2>Teladoc Health 的机构交易</h2>
</div><p>Several large investors have recently modified their holdings of TDOC. Golden State Wealth Management LLC lifted its stake in Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after buying an additional 1,690 shares in the last quarter. Versant Capital Management Inc boosted its stake in shares of Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock valued at $29,000 after acquiring an additional 2,441 shares during the last quarter. Whipplewood Advisors LLC purchased a new stake in Teladoc Health during the 4th quarter worth about $29,000. Lindbrook Capital LLC raised its stake in Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after purchasing an additional 1,612 shares during the last quarter. Finally, Sterling Capital Management LLC lifted its holdings in Teladoc Health by 776.7% in the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after purchasing an additional 4,101 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>几家大型投资者最近调整了对 TDOC 的持股。Golden State Wealth Management LLC 在第一季度将其在 Teladoc Health 的持股增加了 102.6%。Golden State Wealth Management LLC 现在拥有 3,337 股该健康服务提供商的股票，价值 27,000 美元，此前在上个季度又购买了 1,690 股。Versant Capital Management Inc 在第四季度将其在 Teladoc Health 的持股增加了 313.8%。Versant Capital Management Inc 现在拥有 3,219 股该健康服务提供商的股票，价值 29,000 美元，此前在上个季度又收购了 2,441 股。Whipplewood Advisors LLC 在第四季度购买了 Teladoc Health 的新股份，价值约为 29,000 美元。Lindbrook Capital LLC 在第四季度将其在 Teladoc Health 的持股增加了 78.9%。Lindbrook Capital LLC 现在拥有 3,654 股该健康服务提供商的股票，价值 33,000 美元，此前在上个季度又购买了 1,612 股。最后，Sterling Capital Management LLC 在第四季度将其在 Teladoc Health 的持股增加了 776.7%。Sterling Capital Management LLC 现在拥有 4,629 股该健康服务提供商的股票，价值 42,000 美元，此前在上个季度又购买了 4,101 股。目前 76.82% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>About Teladoc Health</h2>
<div class="lb-trans"><h2>关于 Teladoc Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.</p>
<div class="lb-trans"><p>Teladoc Health, Inc 在全球提供虚拟医疗服务。该公司通过 Teladoc Health 综合护理和 BetterHelp 两个部门运营。综合护理部门提供虚拟医疗服务，包括普通医疗、专家医疗、专科医疗、慢性病管理和心理健康，以及为医院和健康系统提供的技术和企业远程医疗解决方案。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另请参阅</h2>
</div><ul>
<li>Five stocks we like better than Teladoc Health</li>
<li>Dividend Screener: How to Evaluate Dividend Stocks Before Buying</li>
<li>Short Sellers Gave Up on These 3 Names Recently</li>
<li>3 Ways To Invest In Coffee, Other Than Drinking It</li>
<li>3 Boring Stocks Outperforming the Market This Year</li>
<li>Insider Trading - What You Need to Know</li>
<li>If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Teladoc Health</li>
<li>股息筛选器：如何在购买前评估股息股票</li>
<li>空头最近放弃了这 3 只股票</li>
<li>除了喝咖啡，还有 3 种投资咖啡的方法</li>
<li>3 只表现优于市场的无聊股票</li>
<li>内部交易 - 你需要知道的事项</li>
<li>如果你想购买 AbbVie 却没有，现在仍然有机会购买</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRET0M" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=TDOC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Teladoc Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Teladoc Health 吗？</h2>
</div><p>Before you consider Teladoc Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Teladoc Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Teladoc Health 并不在名单上。</p>
</div><p>While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Teladoc Health 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Citigroup Cuts Teladoc Health (NYSE:TDOC) Price Target to $8.75

花旗集团将 Teladoc Health（NYSE:TDOC）的目标股价下调至 8.75 美元